Results of a phase 1 study of quizartinib as maintenance therapy in subjects with acute myeloid leukemia in remission following allogeneic hematopoietic stem cell transplant

Publisher： John Wiley & Sons Inc

E-ISSN： 1096-8652|93|2|222-231

ISSN： 0361-8609

Source： AMERICAN JOURNAL OF HEMATOLOGY, Vol.93, Iss.2, 2018-02, pp. : 222-231

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Impact of early remission by induction therapy on allogeneic stem cell transplantation for acute myeloid leukemia with an intermediate‐risk karyotype in first complete remission

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 94, Iss. 5, 2015-05 ,pp. : 431-438

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sorafenib treatment following hematopoietic stem cell transplant in pediatric FLT3/ITD acute myeloid leukemia

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 6, 2015-06 ,pp. : 1048-1054

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparison of umbilical cord blood allogeneic stem cell transplantation vs. auto‐SCT for adult acute myeloid leukemia patients in second complete remission at transplant: a retrospective study on behalf of the SFGM‐TC

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 94, Iss. 5, 2015-05 ,pp. : 449-455

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase 1 study of quizartinib in combination with induction and consolidation chemotherapy in patients with newly diagnosed acute myeloid leukemia

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 93, Iss. 2, 2018-02 ,pp. : 213-221

John Wiley & Sons Inc

Access to resources Recommend Favorite

Autologous Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia in First Complete Remission: A Meta-Analysis of Randomized Trials

By  

Acta Haematologica, Vol. 124, Iss. 2, 2010-07 ,pp. : 61-71

Karger

Access to resources Recommend Favorite